Amanta Healthcare Limited (NSE:AMANTA)
India · Delayed Price · Currency is INR 228.37
+32.33 (16.49%)
At close: Nov 12, 2026
Amanta Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,034 | 2,877 | 2,747 | 2,803 | 2,591 | 2,254 |
Other Revenue | 1.67 | 1.67 | - | - | - | - |
| 3,036 | 2,878 | 2,747 | 2,803 | 2,591 | 2,254 | |
Revenue Growth | 9.97% | 4.78% | -2.01% | 8.19% | 14.94% | 31.61% |
Cost of Revenue | 1,107 | 986.5 | 961.38 | 1,051 | 1,018 | 767.95 |
Gross Profit | 1,929 | 1,892 | 1,786 | 1,752 | 1,574 | 1,486 |
Selling, General & Admin | 468.89 | 442.93 | 363.88 | 326.12 | 326.62 | 292.41 |
Other Operating Expenses | 837.2 | 848.25 | 825.14 | 851.33 | 715.02 | 657.78 |
Operating Expenses | 1,500 | 1,478 | 1,373 | 1,375 | 1,225 | 1,123 |
Operating Income | 428.75 | 413.45 | 412.7 | 377.6 | 348.57 | 363.49 |
Interest Expense | -228.42 | -224.32 | -269.66 | -323.97 | -343.85 | -430.58 |
Interest & Investment Income | 12.62 | 12.62 | 3.09 | 3.29 | 8.05 | 3.35 |
Currency Exchange Gain (Loss) | 8.81 | 8.81 | 0.68 | - | 18.98 | 3.17 |
Other Non Operating Income (Expenses) | 26.22 | 22.55 | -7.97 | -5.87 | -8.52 | -8.36 |
EBT Excluding Unusual Items | 247.97 | 233.11 | 138.84 | 51.05 | 23.23 | -68.93 |
Gain (Loss) on Sale of Investments | 2.82 | 2.82 | 5.01 | 2.48 | 1.33 | 1.31 |
Gain (Loss) on Sale of Assets | -0.5 | -0.5 | - | - | -4.64 | - |
Other Unusual Items | 0.7 | -25.58 | 1.85 | - | 5.34 | 685.23 |
Pretax Income | 252.39 | 211.25 | 147.07 | 53.89 | 26.9 | 617.87 |
Income Tax Expense | 69.07 | 62.5 | 42.06 | 17.56 | 48.01 | 79.06 |
Net Income | 183.32 | 148.75 | 105.01 | 36.33 | -21.11 | 538.82 |
Net Income to Common | 183.32 | 148.75 | 105.01 | 36.33 | -21.11 | 538.82 |
Net Income Growth | 37.62% | 41.66% | 189.02% | - | - | - |
Shares Outstanding (Basic) | 37 | 34 | 28 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 37 | 34 | 28 | 27 | 27 | 27 |
Shares Change | 16.75% | 21.46% | 5.37% | -0.00% | - | 0.00% |
EPS (Basic) | 5.01 | 4.33 | 3.71 | 1.35 | -0.79 | 20.08 |
EPS (Diluted) | 5.01 | 4.33 | 3.71 | 1.35 | -0.79 | 20.08 |
EPS Growth | 17.94% | 16.71% | 174.81% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -653.4 | -317.4 | 258.46 | 446.62 | 362.9 | 535.62 |
Free Cash Flow Per Share | -17.86 | -9.24 | 9.14 | 16.65 | 13.53 | 19.96 |
Gross Margin | 63.53% | 65.73% | 65.00% | 62.51% | 60.73% | 65.94% |
Operating Margin | 14.12% | 14.36% | 15.02% | 13.47% | 13.45% | 16.12% |
Profit Margin | 6.04% | 5.17% | 3.82% | 1.30% | -0.81% | 23.90% |
Free Cash Flow Margin | -21.52% | -11.03% | 9.41% | 15.93% | 14.00% | 23.76% |
EBITDA | 601.62 | 579.72 | 578.47 | 548.72 | 513.77 | 527.72 |
EBITDA Margin | 19.82% | 20.14% | 21.06% | 19.57% | 19.83% | 23.41% |
D&A For EBITDA | 172.87 | 166.26 | 165.77 | 171.12 | 165.2 | 164.24 |
EBIT | 428.75 | 413.45 | 412.7 | 377.6 | 348.57 | 363.49 |
EBIT Margin | 14.12% | 14.36% | 15.02% | 13.47% | 13.45% | 16.12% |
Effective Tax Rate | 27.37% | 29.58% | 28.60% | 32.58% | 178.46% | 12.80% |
Revenue as Reported | 3,072 | 2,910 | 2,761 | 2,816 | 2,627 | 2,263 |